|
|
|
Insider
Information: |
Enright Patrick G |
Relationship: |
10% Owner |
City: |
Burlingame |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
16 |
|
Direct
Shares |
3,308,185 |
|
Indirect Shares
|
27,432,603 |
|
|
Direct
Value |
$11,226,281 |
|
|
Indirect Value
|
$115,355,470 |
|
|
Total
Shares |
30,740,788 |
|
|
Total
Value |
$126,581,751 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
6
|
1
|
Stock
price went up :
|
5
|
1
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
5.0
|
1.0
|
Percentage
Gain/Loss : |
95.0%
|
101.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Molecular Templates, Inc. |
MTEM |
Director |
2006-04-20 |
496 |
2007-03-01 |
0 |
Premium* |
|
Sequenom Inc |
SQNM |
Director |
2006-12-07 |
771 |
2006-12-07 |
3,333,333 |
Premium* |
|
Corcept Therapeutics Inc |
CORT |
Director |
2017-03-16 |
272,281 |
2017-03-16 |
114,675 |
Premium* |
|
Jazz Pharmaceuticals Inc |
JAZZ |
Director |
2023-08-14 |
20,946 |
2022-08-08 |
2,000 |
Premium* |
|
Esperion Therapeutics, Inc. |
ESPR |
Director |
2013-07-01 |
0 |
2015-03-19 |
18,361 |
Premium* |
|
Collegium Pharmaceutical, Inc |
COLL |
10% Owner |
2015-05-12 |
0 |
2015-05-12 |
65,270 |
Premium* |
|
Aimmune Therapeutics, Inc. |
AIMT |
Director |
2020-10-13 |
0 |
2020-10-10 |
0 |
Premium* |
|
Aptinyx Inc. |
APTX |
Director |
2020-01-10 |
95,000 |
2020-01-10 |
3,356,746 |
Premium* |
|
Tricida, Inc. |
TCDA |
|
2018-07-02 |
0 |
2018-07-02 |
3,019,734 |
Premium* |
|
Venus Concept Inc |
VERO |
10% Owner |
|
0 |
2019-11-07 |
3,666,119 |
Premium* |
|
89bio, Inc. |
ETNB |
10% Owner |
2019-11-11 |
0 |
2020-11-16 |
891 |
Premium* |
|
Sierra Oncology Inc |
SRRA |
10% Owner |
2020-01-29 |
0 |
2022-01-25 |
1,964,771 |
Premium* |
|
Inozyme Pharma, Inc. |
INZY |
10% Owner |
2020-07-28 |
0 |
2022-04-19 |
4,174,379 |
Premium* |
|
Eargo, Inc. |
EAR |
10% Owner |
2021-04-14 |
2,918,691 |
2021-04-14 |
5,012 |
Premium* |
|
Vera Therapeutics, Inc. |
VERA |
Director, 10% Owner |
2021-05-18 |
0 |
2023-02-06 |
5,144,212 |
Premium* |
|
Lexeo Therapeutics, Inc. |
LXEO |
10% Owner |
2023-11-07 |
0 |
2023-11-07 |
2,567,100 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2014-02-28 |
4 |
S |
$150.50 |
$83,507,487 |
I/I |
(547,867) |
7,858 |
0 |
- |
|
ESPR |
Esperion Therapeutics, In... |
Director |
|
2015-03-19 |
4 |
S |
$110.01 |
$55,831,597 |
I/I |
(500,000) |
18,361 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2013-03-05 |
4 |
S |
$58.28 |
$46,624,000 |
I/I |
(800,000) |
15,422 |
0 |
- |
|
ESPR |
Esperion Therapeutics, In... |
Director |
|
2014-11-17 |
4 |
S |
$32.01 |
$15,804,823 |
I/I |
(482,026) |
28,286 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2017-02-23 |
4 |
S |
$8.65 |
$12,975,000 |
I/I |
(1,500,000) |
185,807 |
0 |
- |
|
VERA |
Vera Therapeutics, Inc. |
Director |
|
2023-02-06 |
4 |
B |
$7.00 |
$11,999,995 |
I/I |
1,714,285 |
1,714,285 |
2.25 |
- |
|
INZY |
Inozyme Pharma, Inc. |
10% Owner |
|
2020-07-28 |
4 |
B |
$16.00 |
$10,000,000 |
I/I |
625,000 |
2,819,379 |
1.5 |
- |
|
VERA |
Vera Therapeutics, Inc. |
Director |
|
2021-05-18 |
4 |
B |
$11.00 |
$9,999,990 |
I/I |
909,090 |
3,096,594 |
2.25 |
- |
|
ETNB |
89bio, Inc. |
10% Owner |
|
2019-11-11 |
4 |
B |
$16.00 |
$9,200,000 |
I/I |
575,000 |
575,000 |
1.5 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2017-02-27 |
4 |
S |
$9.05 |
$9,050,000 |
I/I |
(1,000,000) |
166,157 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2010-05-11 |
4 |
B |
$8.35 |
$6,999,997 |
I/I |
838,323 |
56,667 |
2.1 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2009-07-07 |
4 |
A |
$3.63 |
$6,881,514 |
I/I |
1,895,734 |
37,248 |
0 |
- |
|
SRRA |
Sierra Oncology Inc |
10% Owner |
|
2022-01-25 |
4 |
OE |
$13.20 |
$6,434,353 |
I/I |
487,451 |
1,964,771 |
0 |
- |
|
AIMT |
Aimmune Therapeutics, Inc... |
Director |
|
2015-08-11 |
4 |
B |
$16.00 |
$5,000,000 |
I/I |
312,500 |
7,434,630 |
2.25 |
- |
|
VERA |
Vera Therapeutics, Inc. |
Director |
|
2022-02-10 |
4 |
B |
$15.00 |
$4,999,995 |
I/I |
333,333 |
3,429,927 |
2.25 |
- |
|
LXEO |
Lexeo Therapeutics, Inc. |
10% Owner |
|
2023-11-07 |
4 |
B |
$11.00 |
$4,999,995 |
I/I |
454,545 |
2,567,100 |
1.5 |
- |
|
INZY |
Inozyme Pharma, Inc. |
10% Owner |
|
2022-04-19 |
4 |
B |
$3.69 |
$4,999,950 |
I/I |
1,355,000 |
4,174,379 |
1.5 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2012-10-02 |
4 |
AS |
$58.59 |
$3,907,709 |
I/I |
(66,650) |
33,752 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2014-02-28 |
4 |
OE |
$4.00 |
$3,791,468 |
I/I |
947,867 |
18,624 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2015-03-30 |
4 |
OE |
$4.05 |
$3,469,408 |
I/I |
856,644 |
194,958 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2009-10-16 |
4 |
B |
$1.38 |
$3,377,623 |
I/I |
2,447,553 |
10,970,285 |
2.25 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2009-02-06 |
4 |
B |
$0.69 |
$3,189,643 |
I/I |
4,642,857 |
8,522,732 |
2.25 |
- |
|
AIMT |
Aimmune Therapeutics, Inc... |
Director |
|
2020-10-10 |
4 |
D |
$34.50 |
$3,163,547 |
I/I |
(91,697) |
0 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2016-11-17 |
4 |
S |
$9.64 |
$3,135,580 |
I/I |
(325,153) |
185,133 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2015-03-20 |
4 |
S |
$5.85 |
$3,132,072 |
I/I |
(535,397) |
178,125 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|